Estradiol acetylsalicylate
Clinical data | |
---|---|
Other names | Estradiol 3-acetylsalicylate; Acetylsalicylate estradiol |
Routes of administration | By mouth |
Drug class | Estrogen; Estrogen ester |
Identifiers | |
| |
JSmol) | |
| |
|
Estradiol acetylsalicylate, or estradiol 3-acetylsalicylate, is a
acetylsalicylic acid (aspirin) ester of estradiol – which was described in the late 1980s and was never marketed.[1][2][3][4][5] In dogs, the oral bioavailability of estradiol acetylsalicylate was found to be 17-fold higher than that of unmodified estradiol.[1][4] However, a subsequent study found that the oral bioavailability of estradiol and estradiol acetylsalicylate did not differ significantly in rats (4.3% and 4.2%, respectively), suggestive of a major species difference.[2][4][6]
See also
References
- ^ S2CID 7308414.
- ^ ISSN 0378-5173.
- ISBN 978-3-642-60107-1.
- ^ ISBN 978-0-387-49785-3.
- ISBN 978-3-527-63318-0.
- ISSN 0378-5173.